Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment

Mitotane is used as a post-operative adjuvant treatment for patients with adrenocortical carcinoma. Monitoring of plasma mitotane concentrations is recommended, but we do not know what impact target concentrations have on patient outcome. To answer this question, we retrospectively analyzed patient...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med
Hlavní autoři: Puglisi, Soraya, Calabrese, Anna, Basile, Vittoria, Ceccato, Filippo, Scaroni, Carla, Simeoli, Chiara, Torlontano, Massimo, Cannavò, Salvatore, Arnaldi, Giorgio, Stigliano, Antonio, Malandrino, Pasqualino, Saba, Laura, Altieri, Barbara, Della Casa, Silvia, Perotti, Paola, Berchialla, Paola, De Filpo, Giuseppina, Canu, Letizia, Loli, Paola, Reimondo, Giuseppe, Terzolo, Massimo
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6912753/
https://ncbi.nlm.nih.gov/pubmed/31684071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8111850
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky